Bill Snyder

Mimi Baird had not seen or heard from her father since the Harvard-trained physician, tormented by severe bipolar disease, walked away from his family when she was 5 years old. Baird will discuss her memoir on the topic April 19 at the Adventure Science Center. Read More

An estimated 5 billion people — two-thirds of the world’s population — do not have access to surgery because of a lack of facilities, money and trained surgeons and anesthesiologists. Read More

It’s been known for some time that the immune system can produce antibodies capable of “neutralizing” HIV, and stopping the AIDS-causing virus dead in its tracks. Read More

A business plan for a robotic neurosurgical device invented by Vanderbilt University engineers won top honors last week at the sixth annual TechVenture Challenge. Read More

Philip Low, Ph.D., director of the Purdue Center for Drug Discovery, will deliver the next Flexner Discovery Lecture on April 14. Read More

Vanderbilt University Medical Center has entered into a strategic research agreement with Celgene Corporation, a biopharmaceutical company based in Summit, New Jersey. Read More

Robert Lefkowitz, M.D., who shared the 2012 Nobel Prize in Chemistry for his studies of G protein-coupled receptors (GPCRs), will deliver the next Flexner Discovery Lecture on March 31. Read More

Researchers at Vanderbilt University Medical Center have “turned back the clock” in a mouse model of metaplasia — precancerous stomach lesions — raising hopes that gastric cancer, a worldwide scourge that’s rising in the United States, can be prevented. Read More

Laboratory and administrative personnel at Vanderbilt University Medical Center were honored last week for research excellence during the 12th annual Research Staff Awards luncheon at the University Club. Read More

An international research team led by scientists from Vanderbilt University Medical Center has identified a genetic variant that protects people with HIV from developing active tuberculosis. The variant is near the gene encoding the infection-fighting cytokine IL-12. Read More

Lisa Poole, a graduate student in the lab of David Cortez, Ph.D., received the 2016 Leon W. Cunningham Award for Excellence in Biochemistry last week during the Biochemistry Department’s annual retreat at the Student Life Center. Read More

On the evening of June 12, 2015, Donna Emley took two acetaminophen (Tylenol) for a slight muscle ache and went to bed. The next day, she and her husband drove to Kentucky, where they were planning to spend a week at an organic farm. She awoke at 2 a.m. the… Read More

Pioneering Vanderbilt diabetes researcher Charles R. “Rollo” Park, M.D., celebrated his 100th birthday on March 2 at the Heritage of Brentwood with his wife of more than 70 years, Jane Park, Ph.D., professor emerita of Molecular Physiology and Biophysics. Read More

A new animal model can be used to “dissect” the inflammatory response to infection. Read More

Researchers at Vanderbilt University Medical Center have isolated human antibodies against a type of bird flu that has killed more than 200 people in China since 2012 and which may pose a worldwide pandemic threat. Read More

Researchers at Vanderbilt University Medical Center have relieved symptoms in a mouse model of Rett syndrome with a drug-like compound that works like the dimmer switch in an electrical circuit. Read More

Mother-to-child transmission of the human immunodeficiency virus (HIV), which causes AIDS, is still a major problem in resource-limited, rural areas of the world where health care providers are scarce. Read More

Vanderbilt researcher Eduard Chekmenev, Ph.D., has been elected to the Russian Academy of Sciences (RAS) for his efforts to develop imaging markers for cancer and lung disease using hyperpolarized magnetic resonance imaging (MRI). Read More

March is Brain Awareness Month at Vanderbilt, and the public is invited to hear national experts discuss their research on autism and other brain disorders. Read More

C. Michael Stein, MBChB., and his colleagues at Vanderbilt University Medical Center have received a five-year, $1.35 million award from the Arthritis Foundation to develop new biomarkers for rheumatoid arthritis that also may revolutionize treatment. Read More